Conference abstract · 16 Apr 2022
Conference abstractPublished 16 Apr 2022
7-ethyl-10-hydroxy-camptothecin (sn38)
Mashhad University of Medical Sciences, Iran
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objective: 7-Ethyl-10-hydroxy-camptothecin (SN38) is the most biologically active member of camptothecins but the usage of drug was restricted because of its poor solubility in pharmaceutical solvents. Irinotecan as a prodrug of SN38 is the only commercially available formulation of this group but individual differences induce different metabolism rate of Irinotecan to SN38. In this study, we investigated the effect of aptamer functionalization on therapeutic efficiency of PAMAM dendrimers containing SN38. Methods and Materials: AS1411 aptamer conjugated formulation of PEGylated PAMAM containing SN38 was prepared. Nanoparticles were characterized for drug loading and PEGylation efficiency. In vitro cytotoxicity and cellular uptake of SN38 in prepared formulations after 3 hours of exposure to murine colon carcinoma (C-26) cell line were investigated. Then in vivo antitumor efficacy and survival analysis were studied in C-26 mice bearing tumor during 54 days. Result: In vitro evaluations revealed significantly higher cytotoxicity and much lower IC50 for all preparations compared to SN38 solution. Cellular uptake studies showed a higher values of uptake for aptamer conjugated formulations after 3 hours of exposure. Regarding to in vivo results, all prepared formulations improved survival of animal model. All PEGylated formulations conjugated with aptamer in dose of 1 mg/Kg and 2 mg/Kg and formulation conjugated with aptamer in dose of 2 mg/Kg indicated significantly better tumor growth inhibition compared to Irinotecan (25 mg/Kg). Conclusion: The results of this study showed that encapsulation of SN38 in dendrimer and modification of dendrimer by A1411 aptamer improved the anti-tumor effect of drug. Keywords: 7-Ethyl-10-hydroxycamptothecin (SN38), Irinotecan, Camptothecins, Chemotherapy, Poly (amidoamine) (PAMAM) dendrimer, AS1411 aptamer.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 30 Dec 2023
Isolation, Purification and Anti-Cancer Potency of Novel Compound 6-Ethyl-3-Hydroxy-4-Methyl-8aH-Xanthen-9(10aH)-One from Mesua ferrea Linn from Western Ghats of Karnataka
Research article · 30 Apr 2021
Synthesis, Characterization and Biological studies on 3d-metal complexes of 5-[(1, 5-dimethyl-3-oxo-2-phenyl-2, 3-dihydro-1H-pyrazol-4-yl) diazenyl]-1-ethyl-6-hydroxy-4-methyl-2-oxo-1, 2-dihydropyridine-3-carbonitrile
Research article · 3 May 2019
Formulation and evaluation of pH sensitive poly(acrylic acid-co-hydroxy ethyl methacrylate) hydrogels for specific site drug delivery
Short communication · 17 May 2016
Release Studies Of Nimesulide From Ethyl Cellulose And Ethyl Cellulose And Hydroxy Propyl Methyl Cellulose Matrices
More from this journal
The newest in Clinical Pharmacology & Biopharmaceutics.
Research article · 27 Jul 2026
Qualitative LC/MS Assessment of Fenfluramine Hydrochloride After Dilution in Purified Water : A Preliminary Study and Case Report
Article · 20 Jul 2026
Population Pharmacology: Precision Dosing for Diverse Patients
Article · 17 Jul 2026
Therapeutic Drug Monitoring: Optimizing Therapy, Minimizing Toxicity
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Pharmacology & Biopharmaceutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Kiana Sherkat Sadi”
